FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211156732> ?p ?o ?g. }

• W4211156732 endingPage "1014" @default.
• W4211156732 startingPage "1006" @default.
• W4211156732 abstract "Brain metastasis is rare in ovarian cancer patients. The results of Gamma Knife radiosurgery (GKRS) for the treatment of patients with brain metastases from ovarian cancer were retrospectively analyzed to derive the efficacy and prognostic factors for survival and local tumor control. Further histopathological analysis was also performed.The authors retrospectively reviewed the medical records of 118 patients with 566 tumors who had undergone GKRS at the 10 GKRS institutions in Japan.After the initial GKRS, the median overall survival time was 18.1 months. Multivariate analysis showed that uncontrolled primary cancer (p = 0.003) and multiple intracranial metastases (p = 0.034) were significant unfavorable factors. Ten patients died of uncontrolled brain metastases at a median of 17.1 months. The 6-, 12-, and 24-month neurological death rates were 3.2%, 4.6%, and 11.9%, respectively. The 6-, 12-, and 24-month neurological deterioration rates were 7.2%, 13.5%, and 31.4%, respectively. The 6-, 12-, and 24-month distant brain control failure rates were 20.6%, 40.2%, and 42.3%, respectively. Median tumor volume was 1.6 cm3 and marginal dose was 20 Gy. The 6-, 12-, and 24-month local tumor control rates were 97.6%, 95.2%, and 88.0%, respectively. Peritumoral edema (p = 0.043), more than 7-cm3 volume (p = 0.021), and prescription dose less than 18 Gy (p = 0.014) were factors that were significantly correlated in local tumor control failure. Eight patients had symptomatic radiation injury. The 6-, 12-, and 24-month GKRS-related complication rates were 3.3%, 7.8%, and 12.2%, respectively. Primary ovarian cancer was histopathologically diagnosed for 313 tumors in 69 patients. Serous adenocarcinoma was found in 37 patients and other types in 32 patients. Median survival times were 32.3 months for the serous type and 17.4 months for other types after initial GKRS. Patients with serous-type tumors survived significantly longer than patients with other types (p = 0.039). The 6-, 12-, and 24-month local tumor control rates were 100%, 98.8%, and 98.8%, respectively. Serous-type tumors were a significantly good prognosis factor for local tumor control after GKRS (p = 0.005).This study established a relationship between the efficacy of GKRS treatment for brain metastases and the histological type of primary ovarian cancer. GKRS for ovarian cancer brain metastasis can provide satisfactory survival and local control, especially in cases of serous adenocarcinoma." @default.
• W4211156732 created "2022-02-13" @default.
• W4211156732 creator A5002750718 @default.
• W4211156732 creator A5006399718 @default.
• W4211156732 creator A5015280071 @default.
• W4211156732 creator A5015660729 @default.
• W4211156732 creator A5023534350 @default.
• W4211156732 creator A5023738480 @default.
• W4211156732 creator A5037158463 @default.
• W4211156732 creator A5037552072 @default.
• W4211156732 creator A5044432222 @default.
• W4211156732 creator A5056827006 @default.
• W4211156732 creator A5086516069 @default.
• W4211156732 creator A5091500955 @default.
• W4211156732 date "2022-10-01" @default.
• W4211156732 modified "2023-10-06" @default.
• W4211156732 title "Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study" @default.
• W4211156732 cites W1515479008 @default.
• W4211156732 cites W1975488534 @default.
• W4211156732 cites W1985729032 @default.
• W4211156732 cites W1995151867 @default.
• W4211156732 cites W1996198278 @default.
• W4211156732 cites W2015393957 @default.
• W4211156732 cites W2028703455 @default.
• W4211156732 cites W2040440051 @default.
• W4211156732 cites W2042027698 @default.
• W4211156732 cites W2049252013 @default.
• W4211156732 cites W2049371477 @default.
• W4211156732 cites W2075812730 @default.
• W4211156732 cites W2080634730 @default.
• W4211156732 cites W2091645181 @default.
• W4211156732 cites W2121960517 @default.
• W4211156732 cites W2127199535 @default.
• W4211156732 cites W2135947389 @default.
• W4211156732 cites W2148504968 @default.
• W4211156732 cites W2335058213 @default.
• W4211156732 cites W2345347336 @default.
• W4211156732 cites W2493056657 @default.
• W4211156732 cites W2576226445 @default.
• W4211156732 cites W2860288606 @default.
• W4211156732 cites W2911188335 @default.
• W4211156732 cites W2921454842 @default.
• W4211156732 cites W2943799690 @default.
• W4211156732 cites W2946432630 @default.
• W4211156732 cites W2985478855 @default.
• W4211156732 cites W2988933638 @default.
• W4211156732 cites W3097513392 @default.
• W4211156732 doi "https://doi.org/10.3171/2021.12.jns212239" @default.
• W4211156732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35148503" @default.
• W4211156732 hasPublicationYear "2022" @default.
• W4211156732 type Work @default.
• W4211156732 citedByCount "2" @default.
• W4211156732 countsByYear W42111567322023 @default.
• W4211156732 crossrefType "journal-article" @default.
• W4211156732 hasAuthorship W4211156732A5002750718 @default.
• W4211156732 hasAuthorship W4211156732A5006399718 @default.
• W4211156732 hasAuthorship W4211156732A5015280071 @default.
• W4211156732 hasAuthorship W4211156732A5015660729 @default.
• W4211156732 hasAuthorship W4211156732A5023534350 @default.
• W4211156732 hasAuthorship W4211156732A5023738480 @default.
• W4211156732 hasAuthorship W4211156732A5037158463 @default.
• W4211156732 hasAuthorship W4211156732A5037552072 @default.
• W4211156732 hasAuthorship W4211156732A5044432222 @default.
• W4211156732 hasAuthorship W4211156732A5056827006 @default.
• W4211156732 hasAuthorship W4211156732A5086516069 @default.
• W4211156732 hasAuthorship W4211156732A5091500955 @default.
• W4211156732 hasConcept C121608353 @default.
• W4211156732 hasConcept C126322002 @default.
• W4211156732 hasConcept C141071460 @default.
• W4211156732 hasConcept C143998085 @default.
• W4211156732 hasConcept C167135981 @default.
• W4211156732 hasConcept C2778164965 @default.
• W4211156732 hasConcept C2779013556 @default.
• W4211156732 hasConcept C2780387249 @default.
• W4211156732 hasConcept C2780427987 @default.
• W4211156732 hasConcept C38180746 @default.
• W4211156732 hasConcept C509974204 @default.
• W4211156732 hasConcept C71924100 @default.
• W4211156732 hasConcept C72563966 @default.
• W4211156732 hasConceptScore W4211156732C121608353 @default.
• W4211156732 hasConceptScore W4211156732C126322002 @default.
• W4211156732 hasConceptScore W4211156732C141071460 @default.
• W4211156732 hasConceptScore W4211156732C143998085 @default.
• W4211156732 hasConceptScore W4211156732C167135981 @default.
• W4211156732 hasConceptScore W4211156732C2778164965 @default.
• W4211156732 hasConceptScore W4211156732C2779013556 @default.
• W4211156732 hasConceptScore W4211156732C2780387249 @default.
• W4211156732 hasConceptScore W4211156732C2780427987 @default.
• W4211156732 hasConceptScore W4211156732C38180746 @default.
• W4211156732 hasConceptScore W4211156732C509974204 @default.
• W4211156732 hasConceptScore W4211156732C71924100 @default.
• W4211156732 hasConceptScore W4211156732C72563966 @default.
• W4211156732 hasIssue "4" @default.
• W4211156732 hasLocation W42111567321 @default.
• W4211156732 hasLocation W42111567322 @default.
• W4211156732 hasOpenAccess W4211156732 @default.
• W4211156732 hasPrimaryLocation W42111567321 @default.
• W4211156732 hasRelatedWork W1728161349 @default.

• next